Navigation Links
Almac has Successful MHRA Inspection at its Clinical Services UK Site
Date:10/17/2010

Almac has Successful MHRA Inspection at its Clinical Services UK Site -- CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biometrics, Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Corporate Expansion, New Products & Services, European Government Click to view news release full screen  

Almac has Successful MHRA Inspection at its Clinical Services UK Site

 

CRAIGAVON, Northern Ireland, October 18, 2010 /PRNewswire/ -- Almac is once again pleased to announce the successful completion of an inspection of its Clinical Services UK facility located in Craigavon by the Medicines and Healthcare products Regulatory Agency (MHRA).

The routine inspection, which took place over four days, from September 13th - September 16th, was conducted by a MHRA inspector who concluded that the site continues to be compliant with EU Good Manufacturing Practices, with no critical or major failures observed.

Commenting on the inspection, Paul O'Connor (Vice President, Quality), said:

"We are extremely pleased with the outcome of our inspection. These successful results are a positive reflection of all the investment Almac has made over the past few years in our facilities and recruitment of the best employees, ensuring that we are a market leader and continue to deliver a high quality service. Quality is at the core of our ethos - we have three MHRA approved facilities globally, including our additional FDA assessed US facilities in Audubon, Pennsylvania and Durham, North Carolina. The very high standards of quality compliance will continue with our new $120 million North American Headquarters in Souderton - scheduled to open during the autumn."

Notes to Editors

About Almac:

The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, biomarker discovery and development, API manufacture, formulation development, clinical trial supply and IXRS technology (IVRS/IWRS), to commercial-scale manufacture. Almac provides services to more than 600 companies, including all the world leaders in the pharmaceutical and biotech sectors.

The company employs over 2,800 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California. Almac has officially gained full possession of its new $120m North American Headquarters, which started in July 2008, and employees will relocate during the fall.

For more information on Almac, please visit http://www.almacgroup.com Contact: Aileen Murphy aileen.murphy@almacgroup.com Tel: +44(0)28-3836-2436
'/>"/>

SOURCE Almac Group
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. University of Nevada, Reno, demonstrates successful sludge-to-power research
2. University of Nevada, Reno demonstrates successful sludge-to-power research
3. New method successfully predicted how oil from Deepwater Horizon spill would spread
4. School-based intervention successfully lowers drinking rates in at risk children
5. Scientists successfully use human induced pluripotent stem cells to treat Parkinsons in rodents
6. Pitt researcher says simple polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico tests
7. Polymer-based filter successfully cleans water, recovers oil in Gulf of Mexico test
8. Cell Transplantation reports consistent and successful islet isolations offer diabetes hope
9. Novel protein essential for successful pregnancy
10. Successful launch for ESAs CryoSat-2 ice satellite
11. Successful genome sequencing of pea aphid is a breakthrough for ecology and agricultural research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... Jan. 4, 2017  CES 2017 – Valencell ... technology, today announced the launch of two new ... the highly-accurate biometric sensor modules that incorporate the ... experience and expertise. The two new designs include ... for hearables, and Benchmark BW2.0, a 2-LED version ...
(Date:12/22/2016)... -- SuperCom (NASDAQ:   SPCB ... Public Safety, HealthCare, and Finance sectors announced today that Leaders in ... implement and deploy a community-based supportive services program to reduce recidivism ... further expanding its presence in the state. ... This new program, which is expected to ...
(Date:12/19/2016)... España y TORONTO , 19 de diciembre de ... Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo ... varios tipos de tumor en 2017, con múltiples sitios previstos a ... ... con objetivo en el factor inhibidor de leucemia (LIF), una citoquina ...
Breaking Biology News(10 mins):
(Date:1/13/2017)... , ... January 13, 2017 , ... ... cuvette-related demand that it has found among its diverse customer base. The latest ... use in most brands electroporators including BTX and Bio-Rad. FireflySci is introducing three ...
(Date:1/12/2017)... (PRWEB) , ... January 12, ... ... USING VTI’S INTERFUSE® IS A SUCCESS , VTI, Vertebral Technologies, Inc., announces ... the InterFuse® laterally expandable device. Since September 2016, VTI (Vertebral Technologies, Inc.) ...
(Date:1/12/2017)... ... January 12, 2017 , ... ... capable of performing routine electrochemical biosensing has increased dramatically. Primarily driven by ... detection and quantification of various analytes in complex samples. , ...
(Date:1/12/2017)... ... January 12, 2017 , ... After her brain cancer ... gave her only a few months to live. Now a paper publishing January ... Rosendahl’s disease and increased both the quantity and quality of her life: Adding ...
Breaking Biology Technology: